STOCKSURGICAL & MEDICAL INSTRUMENTS & APPARATUSUpdated 2026-08-16
Here’s whether Cerus Corp (CERS) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); RSI 47 — healthy momentum range; strong 1-year return of +134.7%; 3-month momentum positive (+27.4%); rising volume confirms the move (1.24x 30d avg). Concerns: 50-day MA is falling (-2.07% over 10 days). Currently 14.1% off its 52-week high. Score: +6/7.
CERS is in a confirmed uptrend, trading above both its 50-day ($2.80) and 200-day ($2.28) moving averages. An RSI of 47.5 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +134.7% compares to +20.4% for SPY (beat the market by 114.3%).
$10,000 invested 1 year ago→ $23,465 today
vs. S&P 500 (SPY) — same period beat market by 114.3%